Clinical utility gene card for: Arrhythmogenic right ventricular cardiomyopathy (ARVC)

European Journal of Human Genetics

Volumn 22, Issue 2, 2014, Pages 293-

  Te Rijdt, Wouter P ^a,b   Jongbloed, Jan D H ^a   De Boer, Rudolf A ^a   Thiene, Gaetano ^c   Basso, Cristina ^c   Van Den Berg, Maarten P ^a   Peter Van Tintelen, J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HISTORY; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENETIC CODE; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART RIGHT VENTRICLE DYSPLASIA; HETEROZYGOSITY; HOLTER MONITORING; HUMAN; MISSENSE MUTATION; NONSENSE MUTATION; PHENOTYPE; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SINGLE NUCLEOTIDE POLYMORPHISM; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; COST BENEFIT ANALYSIS; DIFFERENTIAL DIAGNOSIS; ECONOMICS; GENETICS; MOLECULAR DIAGNOSIS;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; COST-BENEFIT ANALYSIS; DIAGNOSIS, DIFFERENTIAL; GENETIC TESTING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 84892812797     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.124     Document Type: Article

References (26)

1. Marcus FI, McKenna WJ, Sherrill D et al: Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010; 31: 806-814.
2. Tiso N, Stephan DA, Nava A et al: Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10: 189-194.
3. Beffagna G, Occhi G, Nava A et al: Regulatory mutations in transforming growth factorbeta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 2005; 65: 366-373.
4. van der Zwaag PA, Jongbloed JD, van den Berg MP et al: A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat 2009; 30: 1278-1283.
5. Cox MG, van der Zwaag PA, van der Werf C et al: Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation 2011; 123: 2690-2700.
6. Roberts J, Herkert J, Rutberg J et al: Detection of genomic deletions of PKP2 in arrhythmogenic right ventricular cardiomyopathy. Clin Genet 2012; 83: 452-456.
7. Teekakirikul P, Kelly MA, Rehm HL, Lakdawala NK, Funke BH: Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era. J Mol Diagn 2013; 15: 158-170.
8. Nava A, Bauce B, Basso C et al: Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000; 36: 2226-2233.
9. Basso C, Bauce B, Corrado D, Thiene G: Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol 2011; 9: 223-233.
10. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N: Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129-133.
11. Syrris P, Ward D, Asimaki A et al: Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 2006; 113: 356-364.
12. van Tintelen JP, Entius MM, Bhuiyan ZA et al: Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006; 113: 1650-1658.
13. Xu T, Yang Z, Vatta M et al: Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2010; 55: 587-597.
14. van der Zwaag PA, van Rijsingen IA, Asimaki A et al: Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail 2012; 14: 1199-1207.
15. van der Zwaag PA, Cox MG, van der Werf C et al: Recurrent and founder mutations in the Netherlands: Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J 2010; 18: 583-591.
16. Merner ND, Hodgkinson KA, Haywood AF et al: Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 2008; 82: 809-821.
17. Fressart V, Duthoit G, Donal E et al: Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace 2010; 12: 861-868.
18. Bauce B, Nava A, Beffagna G et al: Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Heart Rhythm 2010; 7: 22-29.
19. Kapplinger JD, Landstrom AP, Salisbury BA et al: Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol 2011; 57: 2317-2327.
20. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ: Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007; 115: 1710-1720.
21. Antoniades L, Tsatsopoulou A, Anastasakis A et al: Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis. Eur Heart J 2006; 27: 2208-2216.
22. Paul M, Stypmann J, Gerss J et al: Safety of endomyocardial biopsy in patients with arrhythmogenic right ventricular cardiomyopathy: a study analyzing 161 diagnostic procedures. JACC Cardiovasc Interv 2011; 4: 1142-1148.
23. Corrado D, Basso C, Leoni L et al: Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2005; 111: 3042-3050.
24. Marra MP, Leoni L, Bauce B et al: Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol 2012; 5: 91-100.
25. Wordsworth S, Leal J, Blair E et al: DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. Eur Heart J 2010; 31: 926-935.
26. Hodgkinson KA, Connors SP, Merner N et al: The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43. Clin Genet 2013; 83: 321-331.